Specific inhibition of nitric oxide production in macrophages by phosphorothioate antisense oligonucleotides

Journal of Pharmaceutical Sciences

Volumn 86, Issue 10, 1997, Pages 1079-1084

  Arima, Hidetoshi ^a   Sakamoto, Takatoshi ^a   Aramaki, Yukihiko ^a   Ishidate, Kozo ^b   Tsuchiya, Seishi ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BETA ACTIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; PHOSPHOROTHIOIC ACID; THIOGLYCOLIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CODON; CONTROLLED STUDY; IMMUNOBLOTTING; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030922810     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js970099g     Document Type: Article

References (55)

1. Nathan, C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992, 6, 3051-3064.
2. Bredt, D. S.; Hwang, P. M.; Glatt, C. E.; Lowenstein, C.; Reed, R. R.; Snyder, S. H. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991, 351, 714-718.
3. Lamas, S.; Marsden, P. A.; Li, G. K.; Tempst, P.; Michel, T. Endothelial nitric oxide synthase: Molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 6348-6352.
4. Xie, Q.; Cho, H. J.; Calaycay, J.; Mumford, R. A.; Swiderek, K. M.; Lee, T. D.; Ding, A.; Troso, T.; Nathan, C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992, 256, 225-228.
5. Sessa, W. C.; Harrison, J. K.; Barber, C. M.; Zeng, D.; Durieux, M. E.; D'Angelo, D. D.; Lynch, K. R.; Peach, M. J. Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J. Biol. Chem. 1992, 267, 15274-15276.
6. Nakane, M.; Schmidt, H.; Pollock, J. S.; Forstermann, U.; Murad, F. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett. 1993, 316, 175-180.
7. Lyons, C. R.; Orloff, G. J.; Cunningham, J. M. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J. Biol. Chem. 1992, 267, 6370-6374.
8. Cho, H. J.; Xie, Q. W.; Calaycay, J.; Mumford, R. A.; Swiderek, K. M.; Lee, T. D.; Nathan, C. Calmodulin is a subunit of nitric oxide synthase from macrophages. J. Exp. Med. 1992, 176, 599-604.
9. White, R.; Brock, T.; Chang, L.-Y.; Crapo, J.; Briscoe, P.; Ku, D.; Bradley, W.; Gianturco, S.; Gore, J.; Freeman, B.; Tarpey, M. Superoxide and peroxynitrite in atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 1044-1048.
10. Nguyen, T.; Brunson, D.; Crespi, C.; Penmann, B.; Wishnok, J.; Tannenbaum, S. DNA damage and mutation in human cells exposed to NO in vitro. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 3030-3034.
11. Radi, R.; Beckman, J.; Bush, K.; Freeman, B. Peroxinitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitrix oxide. Arch. Biochem. Biophys. 1991, 288, 481-487.
12. Petros, A.; Bennett, D.; Vallance, P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991, 338, 1557-1558.
13. Forstermann, U.; Closs, E. I.; Pollock, J. S.; Nakane, M.; Schwarz, P.; Gath, I.; Kleinert, H. Nitric oxide synthase isozymes: Characterization, purification, molecular cloning and functions. Hypertension 1994, 23, 1121-1131.
14. Liu, S.; Adcock, I. M.; Old, R. W.; Barnes, P. J.; Evans, T. W. Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA. Biochem. Biophys. Res. Commun. 1993, 196, 1208-1213.
15. Knowles, R. G.; Moncada, S. Nitric oxide synthases in mammals. Biochem. J. 1994, 298, 249-258.
16. Marietta, M. A. Approaches toward selective inhibition of nitric oxide synthase. J. Med. Chem. 1994, 37, 1899-1907.
17. Haung, Z.; Haung, N.; Panahian, N.; Dalkara, T.; Fishman, M. C.; Moskowitz, M. A. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 1994, 265, 1883-1885.
18. Stein, C. A.; Cheng, Y. C. Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science 1993, 261, 1004-1012.
19. Wagner, R. W. Gene inhibition using antisense oligodeoxynucle-otides. Nature 1994, 372, 333-335.
20. Stec, W. J.; Zon, G.; Egan, W.; Stec, B. Automated solid-phase synthesis, separation, and stereochemistry of phosphorothioate analogues of oligodeoxyribonucleotides. J. Am. Chem. Soc. 1984, 106, 6077-6079.
21. Stein, C. A.; Subasinghe, C.; Shinozuka, K.; Cohen, J. S. Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acid Res. 1988, 16, 3209-3221.
22. Stein, C. A.; Tonkinson, J. L.; Yakubov, L. Phosphorothioate oligodeoxynucleotides-antisense inhibitors of gene expression? Pharmacol. Ther. 1991, 52, 365-384.
23. Thomae, K. R.; Geller, D. A.; Billiar, T. R.; Davies, P.; Pitt, B. R.; Simmons, R. L.; Nakayama, D. K.; Meyer, A.; Buchman, T. G.; Hauser, C. J.; Hunt, T. K.; Merion, R. Antisense oligodeoxynucleotide to inducible nitric oxide synthase inhibits nitric oxide synthesis in rat pulmonary artery smooth muscle cells in culture. Surgery 1993, 114, 272-277.
24. Peresleni, T.; Noiri, E.; Bahou, W. F.; Goligorsky, M. S. Antisense oligodeoxynucleotides to inducible NO synthase rescue epithelial cells from oxidative stress injury. Am. J. Physiol. 1996, 270, f971-977.
25. Noiri, E.; Peresleni, T.; Miller, F.; Goligorsky, M. S. In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J. Clin. Invest. 1996, 97, 2377-2383.
26. Stuehr, D. J.; Nathan, C. F. Nitric oxide: A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 1989, 169, 1543-1555.
27. Aramaki, Y.; Nitta, F.; Matsuno, R.; Morimura, Y.; Tsuchiya, S. Inhibitory effects of negatively charged liposomes on nitric oxide production from macrophages stimulated by LPS. Biochem. Biophys. Res. Commun. 1996, 220, 1-6.
28. Ausubel, F. M.; Brent, R.; Kingston, R. E.; Moore, D. D.; Seidman, J. G.; Smith, J. A.; Struhl, K. (Eds.) Current Protocols in Molecular Biology; John Wiley & Sons, Inc.: New York, 1987; pp 421-428.
29. Tokunaga, K.; Taniguchi, H.; Yoda, K.; Shimizu, M.; Sakiyama, S. Nucleotide sequence of a full-length cDNA for mouse cytoskeletal beta-actin mRNA. Nucleic Acids Res. 1986, 14, 2829.
30. Hailman, E.; Lichenstein, H. S.; Wurfel, M. M. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J. Exp. Med. 1994, 179, 269-277.
31. Wright, S. D.; Ramos, R. A.; Tobias, P. S.; Ulevitch, R. J.; Mathison, J. C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990, 249, 1431-1433.
32. Wickstrom, E.; Bacon, T. A.; Wickstrom, E. L. Down-regulation of c-myc antigen expression in lymphocytes of Eμ-c-myc transgenic mice treated with anti-c-myc DNA methylphosphonates. Cancer. Res. 1992, 52, 6741-6745.
33. Akhtar, S.; Kole, R.; Juliano, R. L. Stability of antisense oligodeoxynucleotide analogs in cellular extracts and sera. Life Sci. 1991, 49, 1793-1801.
34. Shaw, J.-P.; Kent, K.; Bird, J.; Fishback, J.; Froehler, B. Modified deoxyoligonucleotides stable to exonuclease degradation in serum. Nucleic Acids Res. 1991, 19, 747-750.
35. Kitajima, I.; Shinohara, T.; Minor, T.; Bibbs, L.; Bilakovics, J.; Nerenberg, M. Human T-cell leukemia virus type I tax transformation is associated with increased uptake of oligodeoxynucleotides in vitro and in vivo. J. Biol. Chem. 1992, 267, 25881-25888.
36. Kitajima, I.; Shinohara, T.; Bilakovics, J.; Brown, D. A.; Xu, X.; Nerenberg, M. Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-κB. Science 1992, 258, 1792-1795.
37. Kirikae, T.; Schade, F. U.; Kirikae, F.; Rietschel, E. T.; Morrison, D. C. Isolation of a macrophage-like cell line defective in binding of lipopolysaccharide. Influence of serum and lipopolysaccharide chain length on macrophage activation. J. Immunol. 1993, 151, 2742-2752.
38. Ingalls, R.; Golenbock, D. T. CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide. J. Exp. Med. 1995, 181, 1473-1479.
39. Shapira, L.; Takashiba, S.; Champagne, C.; Amar, S.; Van Dyke, T. E. J. Immunol. 1994, 153, 1818-1824.
40. DiNapoli, M. R.; Calderon, C. L.; Lopez, D. M. The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduced expression of the inducible nitric oxide synthase gene. J. Exp. Med. 1996, 183, 1323-1329.
41. Stein, C. A.; Krieg, A. M. Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides. Antisense Res. Dev. 1994, 4, 67-69.
42. Haeuptle, M. T.; Frank, R.; Dobberstein, B. Translation arrest by oligodeoxynucleotides complementary to mRNA coding sequences yields polypeptides of predetermined length. Nucleic Acids Res. 1986, 14, 1427-1448.
43. Ellington, A. D.; Szostak, J. W. In vitro selection of RNA molecules that bind specific ligands. Nature 1990, 346, 818-822.
44. Gao, W. Y.; Han, F. S.; Storm, C.; Egan, W.; Cheng, Y. C. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology. Mol. Pharmacol. 1992, 41, 223-229.
45. Bock, L. C.; Griffin, L. C.; Latham, J. A.; Vermaas, E. H.; Toole, J. J. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 1992, 355, 564-566.
46. Yakubov, L.; Khaled, Z.; Zhang, L. M.; Truneh, A.; Vlassov, V.; Stein., C. A. Oligodeoxynucleotides interact with recombinant CD4 at multiple sites. J. Biol. Chem. 1993, 268, 18818-18823.
47. Stein, C. A. Does antisense exist? Natare Med. 1995, 1, 1119-1121.
48. Sharma, H. W.; Narayanan, R. The therapeutic potential of antisense oligonucleotides. Bioessays 1995, 17, 1055-1063.
49. Pisetsky, D. S. Immunologic consequences of nucleic acid therapy. Antisense Res. Dev. 1995, 5, 219-225.
50. Wyatt, J. R.; Vickers, T. A.; Roberson, J. L.; Buckheit, R. J.; Klimkait, T.; DeBaets, E.; Davis, P. W.; Rayner, B.; Imbach, J. L.; Ecker, D. J. Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 1356-1360.
51. Burgess, T. L.; Fisher, E. F.; Ross, S. L.; Bready, J. V.; Qian, Y. X.; Bayewitch, L. A.; Cohen, A. M.; Herrera, C. J.; Hu, S. F.; Kramer, T. B.; Lott, F. D.; Martin, F. H.; Pierce, G. F.; Simonet, L.; Farrell, C. L. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 4051-4055.
52. Krieg, A. K.; Yi, A.-K.; Matson, S.; Waldschmid, T. J.; Bishop, G. A.; Teasdale, R.; Koretzky, G.; Klinman, D. B cell activation by oligodoxynucleotides that contain stem-loop motif. Nature 1995, 374, 546-549.
53. Liang, H.; Nishioka, Y.; Reich, C. F.; Pisetsky, D. S.; Lipsky, P. E. Activation of human B cells by phosphorothioate oligodeoxynucleotides. J. Clin. Invest. 1996, 98, 1119-1129.
54. Ballas, Z. K.; Rasmussen, W. L.; Krieg, A. M. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol. 1996, 157, 1840-1845.
55. Flesch, I. E. A.; Hess, J. H.; Kaufmann, S. H. E. NADPH diaphorase staining suggests a transient and localized contribution of nitric oxide to host defence against an intracellular pathogen in situ. Int. Immunol. 1994, 6, 1751-1757.